Skip to main content
Premium Trial:

Request an Annual Quote

Ian Dunham, Lothar Krinke, Larry Kier


Genops Bioinformatics, based in Vancouver, BC, has appointed Ian Dunham to its scientific advisory board.

Dunham has worked as senior research fellow in human genetics at the Sanger Center since 1996, where he has overseen Human Chromosome projects 6 and 22. Previous to Sanger, Dunham held research positions at the United Medical and Dental Schools of Guy’s and St. Thomas’ Hospitals’ Division of Medical and Molecular Genetics and the Howard Hughes Medical Institute.

Celera Genomics of Rockville, Md., has appointed Lothar Krinke as vice president, business development and strategic planning.

Krinke’s focus will be on business development and potential mergers and acquisitions directed toward Celera’s Discovery Sciences strategy and the expansion of the group’s Information business.

Prior to Celera, Krinke was a vice president at consulting firm A.T. Kearney, where he was responsible for helping biopharmaceutical companies develop R&D and marketing strategies.

Larry Kier has joined Sante Fe, N.M.-based Phase-1 Molecular Toxicology as director of preclinical research.

Formerly at Monsanto/Pharmacia, Kier will oversee the company’s data mining activities and help develop predictive toxicology methods. He will also contribute to the analysis of data from the company’s TOXbank Canine Database scheduled for release in early 2002.

Filed under

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.